Newron Pharmaceuticals expands IP portfolio for evenamide with new European Union composition of matter patent: Milan, Italy Thursday, January 8, 2026, 14:00 Hrs [IST] Newron Phar ...
EDINBURGH, United Kingdom, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced that the China National Intellectual Property Administration (“CNIPA”) has ...
DALLAS--(BUSINESS WIRE)--Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced the allowance of a composition of ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Ongoing development of PALI-2108 across FSCD and UC, with Phase 2 IND submission planned for H1 2026. Carlsbad, CA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: P ...
Obtaining regulatory approval for small-molecule therapeutics continues to be an arduous and expensive process. Because composition of matter patents are often filed long before first-patient-in, that ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback